Cited by 850Multiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersOcular Diseases and Behçet’s Syndrome

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

Open access

Sato, Douglas Kazutoshi, Callegaro, Dagoberto, Lana-Peixoto, Marco Aurelio, Waters, Patrick J., Jorge, Frederico M. de Haidar, Takahashi, Toshiyuki, Nakashima, Ichiro, Apostolos-Pereira, Samira Luisa, Talim, Natalia, Simm, Renata Faria, Lino, Angelina Maria Martins, Misu, Tatsuro, Leite, Maria Isabel, Aoki, Masashi, Fujihara, Kazuo·2014·Neurology

DOI 10.1212/wnl.0000000000000101PMC PMC3937859

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE: To evaluate clinical features among patients with neuromyelitis optica spectrum disorders (NMOSD) who have myelin oligodendrocyte glycoprotein (MOG) antibodies, aquaporin-4 (AQP4) antibodies, or seronegativity for both antibodies. METHODS: Sera from patients diagnosed with NMOSD in 1 of 3 centers (2 sites in Brazil and 1 site in Japan) were tested for MOG and AQP4 antibodies using cell-based assays with live transfected cells. RESULTS: Among the 215 patients with NMOSD, 7.4% (16/215) were positive for MOG antibodies and 64.7% (139/215) were positive for AQP4 antibodies. No patients were positive for both antibodies. Patients with MOG antibodies represented 21.1% (16/76) of the patients negative for AQP4 antibodies. Compared with patients with AQP4 antibodies or patients who were seronegative, patients with MOG antibodies were more frequently male, had a more restricted phenotype (optic nerve more than spinal cord), more frequently had bilateral simultaneous optic neuritis, more often had a single attack, had spinal cord lesions distributed in the lower portion of the spinal cord, and usually demonstrated better functional recovery after an attack. CONCLUSIONS: Patients with NMOSD with MOG antibodies have distinct clinical features, fewer attacks, and better recovery than patients with AQP4 antibodies or patients seronegative for both antibodies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000000101

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Revised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,568
The spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,182
The clinical course of neuromyelitis optica (Devic’s syndrome)
Wingerchuk, D. M., Hogancamp, W. E., O’Brien, P. C., & Weinshenker, B. G. (1999) · Neurology · doi:10.1212/wnl.53.5.1107 · Cited by 1,819
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre
Takahashi, T., Fujihara, K., Nakashima, I., Misu, T., Miyazawa, I., Nakamura, M., Watanabe, S., Shiga, Y., Kanaoka, C., Fujimori, J., et al. (2007) · Brain · doi:10.1093/brain/awm062 · Cited by 633
Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies: A Comparative Study
Kitley, J., Waters, P., Woodhall, M., Leite, M. I., Murchison, A., George, J., Küker, W., Chandratre, S., Vincent, A., & Palace, J. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5857 · Cited by 597
Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays
Waters, P. J., McKeon, A., Leite, M. I., Rajasekharan, S., Lennon, V. A., Villalobos, A., Palace, J., Mandrekar, J. N., Vincent, A., Bar-Or, A., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318248dec1 · Cited by 526
Self-citation
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
Mader, S., Gredler, V., Schanda, K., Rostasy, K. M., Dujmović, I., Pfaller, K., Lutterotti, A., Jarius, S., Pauli, F. D., Kuenz, B., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-184 · Cited by 449
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
Kitley, J., Woodhall, M., Waters, P., Leite, M. I., Devenney, E., Craig, J., Palace, J., & Vincent, A. (2012) · Neurology · doi:10.1212/wnl.0b013e31826aac4e · Cited by 445
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein
O’Connor, K. C., McLaughlin, K. A., Jager, P. L. D., Chitnis, T., Bettelli, E., Xu, C., Robinson, W. H., Cherry, S. V., Bar‐Or, A., Banwell, B., et al. (2007) · Nature Medicine · doi:10.1038/nm1488 · Cited by 419
The spectrum of MOG autoantibody-associated demyelinating diseases
Reindl, M., Pauli, F. D., Rostasy, K. M., & Berger, T. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.118 · Cited by 376

Show all 21 references

Sorted by citations

Items 301–400 of 848

Clinical Features and Imaging Findings of Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disorder (MOGAD)
Li, Y., Liu, X., Wang, J., Pan, C., & Tang, Z. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.850743 · Cited by 30
Efficiency of antibody therapy in demyelinating diseases
Akaishi, T., & Nakashima, I. (2017) · International Immunology · doi:10.1093/intimm/dxx037 · Cited by 27
The expansion of circulating IL-6 and IL-17-secreting follicular helper T cells is associated with neurological disabilities in neuromyelitis optica spectrum disorders.
Monteiro, C., Fernandes, G., Kasahara, T., Barros, P., Dias, A. S. O., Araújo, A. C. R. A., Ornelas, A. M. M., Aguiar, R. S., Alvarenga, R., & Bento, C. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.01.015 · Cited by 23
Anti-IL-6 Therapies for Neuromyelitis Optica Spectrum Disorders: A Systematic Review of Safety and Efficacy
Lotan, I., McGowan, R., & Levy, M. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200429010825 · Cited by 27
What percentage of AQP4-ab-negative NMOSD patients are MOG-ab positive? A study from the Argentinean multiple sclerosis registry (RelevarEM)
Contentti, E. C., López, P. A., Pettinicchi, J. P., Pappolla, A., Míguez, J., Patrucco, L., Cristiano, E., Vrech, C., Tkachuk, V. A., Liwacki, S., et al. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102742 · Cited by 27
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders
Mao, Z., Lu, Z., & Hu, X. (2014) · Neurology · doi:10.1212/wnl.0000000000000830 · Cited by 27
Different blood-brain-barrier disruption profiles in multiple sclerosis, neuromyelitis optica spectrum disorders, and neuropsychiatric systemic lupus erythematosus
Jasiak-Zatońska, M., Pietrzak, A., Wyciszkiewicz, A., Więsik–Szewczyk, E., Pawlak-Buś, K., Leszczyński, P., Kozubski, W. P., Michalak, S., & Kalinowska, A. (2022) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2022.0013 · Cited by 26
Anti-MOG antibody–associated disorders: differences in clinical profiles and prognosis in Japan and Germany
Liu, J., Mori, M., Zimmermann, H. G., Brandt, A. U., Havla, J. B., Tanaka, S., Sugimoto, K., Oji, S., Uzawa, A., Asseyer, S., et al. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-324422 · Cited by 25
Clinical and Radiological Features of Adult Onset Bilateral Medial Frontal Cerebral Cortical Encephalitis With Anti-myelin Oligodendrocyte Glycoprotein Antibody
Fujimori, J., Nakamura, M., Yagihashi, T., & Nakashima, I. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.600169 · Cited by 25
Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases
Schanda, K., Peschl, P., Lerch, M., Seebacher, B., Mindorf, S., Ritter, N., Probst, M., Hegen, H., Pauli, F. D., Wendel, E., et al. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001027 · Cited by 27
Update on pathology of central nervous system inflammatory demyelinating diseases
Kalinowska, A., Guo, Y., & Lucchinetti, C. F. (2022) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2022.0046 · Cited by 29
Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) associated with COVID-19: A case series and review
Feizi, P., Sharma, K., Pasham, S. R., Nirwan, L., Joseph, J. T., Jaiswal, S., & Sriwastava, S. (2022) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2022.577939 · Cited by 25
T cell deletional tolerance restricts AQP4 but not MOG CNS autoimmunity
Sagan, S. A., Moinfar, Z., Moseley, C. E., Dandekar, R., Spencer, C. M., Verkman, A. S., Ottersen, O. P., Sobel, R. A., Sidney, J., Sette, A., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2306572120 · Cited by 25
Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India
Pandit, L., Sato, D. K., Mustafa, S., Takahashi, T., D’Cunha, A., Malli, C., Sudhir, A., & Fujihara, K. (2016) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/2055217316675634 · Cited by 25
Expansion of IL-6+ Th17-like cells expressing TLRs correlates with microbial translocation and neurological disabilities in NMOSD patients
Barros, P. O., Dias, A., Kasahara, T. M., Ornelas, A. M. M., Aguiar, R. S., Leon, S. A., Ruiz, A., Marignier, R., Araújo, A. C. R. A., Alvarenga, R. M. P., et al. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.04.001 · Cited by 25
A case of anti-MOG antibody-positive multiphasic disseminated encephalomyelitis co-occurring with unilateral cerebral cortical encephalitis
Fukushima, N., SUZUKI, M. T., Ogawa, R., Hayashi, K., Takanashi, J., & Ohashi, T. (2017) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-001078 · Cited by 25
CSF-S100B Is a Potential Candidate Biomarker for Neuromyelitis Optica Spectrum Disorders
Wei, Y., Chang, H., Li, X., Du, L., Xu, W., Cong, H., Yao, Y., Zhang, X., & Yin, L. (2018) · BioMed Research International · doi:10.1155/2018/5381239 · Cited by 25
Acute epileptic seizures in myelin oligodendrocyte glycoprotein encephalomyelitis and neuromyelitis optica spectrum disorder: A comparative cohort study
Yao, Y., Xu, Y., Ren, H., Zhou, X., Jin, L., Huang, Y., Lü, Q., Yang, X., Zhang, Y., Zhu, Y., et al. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.11.007 · Cited by 25
The two faces of neuromyelitis optica
Weinshenker, B. G., & Wingerchuk, D. M. (2014) · Neurology · doi:10.1212/wnl.0000000000000114 · Cited by 25
Clinical outcomes and prognostic factors in patients with optic neuritis related to NMOSD and MOGAD in distinct ethnic groups from Latin America
Contentti, E. C., López, P. A., Criniti, J. M., Pettinicchi, J. P., Cristiano, E., Patrucco, L., Contreras, E. B., Gómez‐Figueroa, E., Flores-Rivera, J. D. J., Díaz, E. P. C., et al. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104611 · Cited by 24
MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome
Mariotto, S., Monaco, S., Peschl, P., Coledan, I., Mazzi, R., Höftberger, R., Reindl, M., & Ferrari, S. (2017) · BMC Neurology · doi:10.1186/s12883-017-0971-6 · Cited by 24
Characterization of pain syndromes in patients with neuromyelitis optica
Valério, F., Apóstolos‐Pereira, S. L., Sato, D. K., Callegaro, D., Lucato, L. T., Barboza, V. R., da Silva, V. A., Galhardoni, R., Rodrigues, A. L. D. L., Teixeira, M. J., et al. (2020) · European Journal of Pain · doi:10.1002/ejp.1608 · Cited by 25
Optic neuritis classification in 2021
Ducloyer, J., Marignier, R., Wiertlewski, S., & Lebranchu, P. (2021) · European Journal of Ophthalmology · doi:10.1177/11206721211028050 · Cited by 26
Multiple sclerosis and HIV-1 infection: case report of a HIV controller
Chin, J. H. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0335-1 · Cited by 24
Treatment of neuromyelitis optica
Vodopivec, I., Matiello, M., & Prasad, S. (2015) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000202 · Cited by 24
The role of anti-aquaporin 4 antibody in the conversion of acute brainstem syndrome to neuromyelitis optica
Chen, C., Jiang, Y., Lü, X., Gu, F., Kang, Z., Dai, Y., Lu, Z., & Hu, X. (2016) · BMC Neurology · doi:10.1186/s12883-016-0721-1 · Cited by 25
Different Complement Activation Patterns Following C5 Cleavage in MOGAD and AQP4-IgG+NMOSD
Kaneko, K., Kuroda, H., Matsumoto, Y., Sakamoto, N., Yamazaki, N., Yamamoto, N., Umezawa, S., Namatame, C., Ono, H., Takai, Y., et al. (2024) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200293 · Cited by 23
Unfavorable Structural and Functional Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Optic Neuritis
Jelčić, I., Hanson, J. V. M., Lukas, S., Weber, K. P., Landau, K., Pless, M. L., Reindl, M., Weller, M., Martinꝉ, R., Lutterotti, A., et al. (2018) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000000669 · Cited by 23
Spinal Cord Involvement in MS and Other Demyelinating Diseases
Marrodán, M., Gaitán, M. I., & Correale, J. D. (2020) · Biomedicines · doi:10.3390/biomedicines8050130 · Cited by 23
Late onset neuromyelitis optica spectrum disorder with anti‐aquaporin 4 and anti‐myelin oligodendrocyte glycoprotein antibodies
Wang, L., Tan, H., Huang, W., Chang, X., ZhangBao, J., Zhou, L., Lü, C., Wang, M., Lu, J., Zhao, C., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.15239 · Cited by 23
CD19 as a molecular target in CNS autoimmunity
Stüve, O., Warnke, C., Deason, K. L., Stangel, M., Kieseier, B. C., Hartung, H. P., von Büdingen, H. ‐., Centonze, D., Forsthuber, T. G., & Knappertz, V. A. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1313-z · Cited by 23
Post-vaccination MDEM associated with MOG antibody in a subclinical Chlamydia infected boy
Azumagawa, K., Nomura, S., Shigeri, Y., Jones, L. S., Sato, D. K., Nakashima, I., Kashiwagi, M., Tanabe, T., Shimakawa, S., Nakajima, H., et al. (2016) · Brain and Development · doi:10.1016/j.braindev.2016.02.004 · Cited by 23
Serological markers associated with neuromyelitis optica spectrum disorders in South India
Pandit, L., Sato, D. K., Mustafa, S., Takahashi, T., D’Cunha, A., Malli, C., Sudhir, A., & Fujihara, K. (2016) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.192389 · Cited by 24
CV2/CRMP5-antibody-related Paraneoplastic Optic Neuropathy Associated with Small-cell Lung Cancer
Nakajima, M., Uchibori, A., Ogawa, Y., Miyazaki, T., Ichikawa, Y., Kaneko, K., Takahashi, T., Nakashima, I., Shiraishi, H., Motomura, M., et al. (2018) · Internal Medicine · doi:10.2169/internalmedicine.9736-17 · Cited by 23
Additive Effect of Spinal Cord Volume, Diffuse and Focal Cord Pathology on Disability in Multiple Sclerosis
Andělová, M., Uher, T., Krásenský, J., Sobíšek, L., Kusova, E., Srpová, B., Vodehnalová, K., Friedová, L., Motýl, J., Preiningerova, J. L., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00820 · Cited by 23
Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study
Schmidt, F., Chien, C., Kuchling, J., Bellmann–Strobl, J., Ruprecht, K., Siebert, N., Asseyer, S., Jarius, S., Brandt, A. U., Scheel, M., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.499910 · Cited by 23
Distinction between MOG antibody–positive and AQP4 antibody–positive NMO spectrum disorders
Kezuka, T., Tanaka, K., & Matsunaga, Y. (2014) · Neurology · doi:10.1212/wnl.0000000000000636 · Cited by 23
Magnetic resonance imaging diagnosis of demyelinating diseases: An update
Miki, Y. (2019) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12501 · Cited by 22
Myelin Oligodendrocyte Glycoprotein-IgG Contributes to Oligodendrocytopathy in the Presence of Complement, Distinct from Astrocytopathy Induced by AQP4-IgG
Fang, L., Kang, X., Wang, Z., Wang, S., Wang, J., Zhou, Y., Chen, C., Sun, X., Yan, Y., Kermode, A. G., et al. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-019-00375-8 · Cited by 22
Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel
Brill, L., Ganelin‐Cohen, E., Dabby, R., Rabinowicz, S., Zohar‐Dayan, E., Rein, N., Aloni, E., Karmon, Y., & Vaknin‐Dembinsky, A. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.612304 · Cited by 22
The role of complement and complement therapeutics in neuromyelitis optica spectrum disorders
Stathopoulos, P., & Dalakas, M. C. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2022.2105205 · Cited by 22
Lower frequency of antibodies to MOG in Brazilian patients with demyelinating diseases: An ethnicity influence?
Alvarenga, R. M. P., Neri, V. C., Araújo, A. C. R. D. A. E., da Silva, E. B., Alvarenga, M. P., Pereira, A. B. C. N. D. G., Brandão, A. C., Alvarenga-Filho, H., Guimarães, M. P. M., Marignier, R., et al. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.07.026 · Cited by 22
MOG-related disorders: A new cause of imaging-negative myelitis?
Macaron, G., & Ontaneda, D. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519840746 · Cited by 22
The accuracy of flow cytometric cell-based assay to detect anti-myelin oligodendrocyte glycoprotein (MOG) antibodies determining the optimal method for positivity judgement
Sugimoto, K., Mori, M., Liu, J. S., Tanaka, S., Kaneko, K., Oji, S., Takahashi, T., Uzawa, A., Uchida, T., Masuda, H., et al. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.577021 · Cited by 23
Reduced Myelin Signal in Normal-appearing White Matter in Neuromyelitis Optica Measured by 7T Magnetic Resonance Imaging
Chou, I., Tănăsescu, R., Mougin, O. E., Gowland, P. A., Tench, C. R., Whitehouse, W. P., Gran, B., Nikfekr, E., Sharrack, B., Mazibrada, G., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50928-0 · Cited by 24
The occurrence of myelin oligodendrocyte glycoprotein antibodies in aquaporin-4-antibody seronegative Neuromyelitis Optica Spectrum Disorder: A systematic review and meta-analysis
Li, X., Zhang, C., Jia, D., Fan, M., Li, T., Tian, D., Liu, Y., & Shi, F. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103030 · Cited by 23
Optical coherence tomography in central nervous system demyelinating diseases related optic neuritis
Mekhasingharak, N., Laowanapiban, P., Siritho, S., Satukijchai, C., Prayoonwiwat, N., Jitprapaikulsan, J., Chirapapaisan, N., & Siriraj Neuroimmunology Research Group (2018) · International Journal of Ophthalmology · doi:10.18240/ijo.2018.10.12 · Cited by 21
MOG-antibody-associated disease is different from MS and NMOSD and should be considered as a distinct disease entity – Yes
Leite, M. I., & Sato, D. K. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519868796 · Cited by 21
Validation of a Flow Cytometry Live Cell-Based Assay to Detect Myelin Oligodendrocyte Glycoprotein Antibodies for Clinical Diagnostics
Lopez, J. A., Houston, S. D., Tea, F., Merheb, V., Lee, F. X. Z., Smith, S. A. B. C., McDonald, D., Zou, A., Liyanage, G., Pilli, D., et al. (2021) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfab101 · Cited by 21
Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD
Lin, L., Wu, Y., Hang, H., Lu, J., & Ding, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.853891 · Cited by 25
Neuromyelitis Optica Spectrum Disorder: From Basic Research to Clinical Perspectives
Huang, T., Wang, J.-K., Chang, P.-Y., Hsu, Y.-R., Lin, C.-H. D., Lin, K., & Tsai, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147908 · Cited by 23
AQP4-MOG Double-Positive Neuromyelitis Optica Spectrum Disorder: Case Report with Central and Peripheral Nervous System Involvement and Review of Literature
Spiezia, A. L., Carotenuto, A., Iovino, A., Moccia, M., Gastaldi, M., Iodice, R., Tedeschi, E., Petracca, M., Lavorgna, L., D'Ambrosio, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314559 · Cited by 21
Longitudinally extensive optic neuritis in neuromyelitis optica spectrum disorder
Pula, J. H., Kattah, J. C., Keung, B. M., Wang, H., & Daily, J. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.07.049 · Cited by 21
The autoimmune concept of multiple sclerosis
Nicol, B., Salou, M., Laplaud, D. A., & Wekerle, H. (2015) · La Presse Médicale · doi:10.1016/j.lpm.2015.02.009 · Cited by 23
Autoimmunity in visual loss
Petzold, A., Wong, S. H., & Plant, G. T. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63432-0.00020-7 · Cited by 22
Anti– N ‐methyl‐ D ‐aspartate receptor encephalitis with multiphasic demyelination
Kaneko, K., Sato, D. K., Misu, T., Kurosawa, K., Nakashima, I., Fujihara, K., & Aoki, M. (2014) · Annals of Neurology · doi:10.1002/ana.24224 · Cited by 21
The disrupted molecular circadian clock of monocytes and macrophages in allergic inflammation
Teppan, J., Schwanzer, J., Rittchen, S., Bärnthaler, T., Lindemann, J., Nayak, B. B., Reiter, B. F. E., Luschnig, P., Farzi, A., Heinemann, A., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1408772 · Cited by 21
Oligoclonal bands and periventricular lesions in multiple sclerosis will not increase blood-brain barrier permeability
Akaishi, T., Takahashi, T., & Nakashima, I. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.02.020 · Cited by 20
Anti-IL-6 therapies in central nervous system inflammatory demyelinating diseases
Li, J., & Guo, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.966766 · Cited by 22
High level of agreement in a fixed vs. live cell-based assay for antibodies to myelin oligodendrocyte glycoprotein in a real-world clinical laboratory setting
Smith, T., Haven, T. R., Zuromski, L. M., Luong, K., Clardy, S. L., & Peterson, L. K. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1192644 · Cited by 20
Devic's index case: A critical reappraisal – AQP4-IgG-mediated neuromyelitis optica spectrum disorder, or rather MOG encephalomyelitis?
Jarius, S., & Wildemann, B. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.07.014 · Cited by 20
GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review
De Masi, R., & Orlando, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137373 · Cited by 20
Vision Prognosis and Associated Factors of Optic Neuritis in Dependence of Glial Autoimmune Antibodies
Yang, M. C., Wu, Y., Song, H., Lai, M., Li, H., Sun, M., Zhao, J., Fu, J., Xu, X., Xie, L., et al. (2022) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2022.01.015 · Cited by 19
Estimated prevalence of AQP4 positive neuromyelitis optica spectrum disorder and MOG antibody associated disease in São Paulo, Brazil
Silva, G. D., Apóstolos‐Pereira, S. L., & Callegaro, D. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104488 · Cited by 21
The Role of MRI in the Diagnosis of Spinal Cord Tumors
de Paiva, J. L. R., Sabino, J. V., Pereira, F. V., Okuda, P. A., Villarinho, L. D. L., Queiróz, L. D. S., França, M. C., & Reis, F. (2023) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2023.03.012 · Cited by 19
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
Park, S. Y., Kwon, Y. N., Kim, S., Kim, S.-H., Kim, J. K., Kim, J., Nam, T., Min, Y. G., Park, K. S., Park, J., et al. (2023) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2022-330714 · Cited by 19
Clinical characteristics of myelin oligodendrocyte glycoprotein antibody neuromyelitis optica spectrum disorder
Salama, S., Pardo, S., & Levy, M. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.02.023 · Cited by 19
The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders
Qin, C., Chen, B., Tao, R., Chen, M., Ma, X., Shang, K., Wu, L., Wang, W., Bu, B., & Tian, D. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.06.035 · Cited by 19
Novel emerging treatments for NMOSD
Selmaj, K. W., & Selmaj, I. (2019) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2019.0049 · Cited by 19
Autoimmune Encephalitis in the Intensive Care Unit
Diaz‐Arias, L. A., Pardo, C. A., & Probasco, J. C. (2020) · Current clinical neurology · doi:10.1007/978-3-030-36548-6_17 · Cited by 19
Aquaporins and diseases pathogenesis: From trivial to undeniable involvements, a disease‐based point of view
Ala, M., Jafari, R. M., Hajiabbasi, A., & Dehpour, A. R. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30318 · Cited by 19
Normal brain imaging accompanies neuroimmunologically justified, autoimmune encephalomyelitis
Takewaki, D., Lin, Y., Sato, W., Ono, H., Nakamura, M., Araki, M., Okamoto, T., Takahashi, Y., Kimura, Y., Ota, M., et al. (2018) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000456 · Cited by 20
The balanced CEO: a transformational leader and a capable manager.
Dixon, D. L. (1998) · PubMed · Cited by 19
Efficacy and safety of azathioprine for neuromyelitis optica spectrum disorders: A meta-analysis of real-world studies
Luo, D., Wei, R., Tian, X., Chen, C., Ma, L., Li, M., Dong, X., Zhang, E., Zhou, Y. F., & Cui, Y. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102484 · Cited by 18
Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort
Cross, H., Sabiq, F., Ackermans, N., Mattar, A. A. G., Au, S., Woodhall, M. R., Sun, B., Devonshire, V. A., Carruthers, R. L., Sayao, A., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.525933 · Cited by 20
Chiasmatic lesions on conventional magnetic resonance imaging during the first event of optic neuritis in patients with neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein‐associated disease in a Latin American cohort
Contentti, E. C., López, P. A., Criniti, J. M., Pettinicchi, J. P., Cristiano, E., Patrucco, L., Contreras, E. B., Gómez‐Figueroa, E., Flores-Rivera, J. D. J., Díaz, E. P. C., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.15178 · Cited by 19
The Role of Autoantibody Testing in Modern Personalized Medicine
Kayser, C., Dutra, L. A., dos Reis-Neto, E. T., Castro, C. H. D. M., Fritzler, M. J., & Andrade, L. E. C. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08918-6 · Cited by 19
Central nervous system neuroinflammatory disorders in Asian/Pacific regions
Kim, S., & Kim, H. J. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000315 · Cited by 18
Detection of autoantibodies in central nervous system inflammatory disorders: Clinical application of cell-based assays
Molina, R. D., Conzatti, L. P., da Silva, A. P. B., Goi, L. D. S., da Costa, B. K., Machado, D. C., & Sato, D. K. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.101858 · Cited by 19
Epidemiology of Pediatric NMOSD in Germany and Austria
Lechner, C., Breu, M., Wendel, E., Kornek, B., Schanda, K., Baumann, M., Reindl, M., & Rostasy, K. M. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00415 · Cited by 18
MRI-Based Methods for Spinal Cord Atrophy Evaluation: A Comparison of Cervical Cord Cross-Sectional Area, Cervical Cord Volume, and Full Spinal Cord Volume in Patients with Aquaporin-4 Antibody Seropositive Neuromyelitis Optica Spectrum Disorders
Chien, C., Brandt, A. U., Schmidt, F., Bellmann–Strobl, J., Ruprecht, K., Paul, F., & Scheel, M. (2018) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5665 · Cited by 18
Comparing myelin oligodendrocyte glycoprotein antibody (MOG-Ab) and non MOG-Ab associated optic neuritis: Clinical course and treatment outcome
Etemadifar, M., Abbasi, M., Salari, M., Etemadifar, F., & Tavakoli, H. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.10.013 · Cited by 18
Monoclonal Antibody-Based Treatments for Neuromyelitis Optica Spectrum Disorders: From Bench to Bedside
Zhu, W., Zhang, Y., Wang, Z., Fu, Y., & Yan, Y. (2020) · Neuroscience Bulletin · doi:10.1007/s12264-020-00525-3 · Cited by 17
Decreased subcortical T2 FLAIR signal with cortical T2 FLAIR hyperintense lesions in unilateral cerebral cortical encephalitis with myelin oligodendrocyte glycoprotein antibody
Fujimori, J., Ogawa, R., Murata, T., Takai, Y., Misu, T., & Nakashima, I. (2022) · Neuroimmunology Reports · doi:10.1016/j.nerep.2022.100096 · Cited by 17
Pediatric myelin oligodendrocyte glycoprotein antibody-associated disease in southern China: analysis of 93 cases
Li, X., Wu, W., Hou, C., Zeng, Y., Wu, W., Chen, L., Liao, Y., Zhu, H., Tian, Y., Peng, B., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1162647 · Cited by 17
Treatment of myelin oligodendrocyte glycoprotein immunoglobulin G–associated disease
Healy, S., Elhadd, K. T., Gibbons, E. L., Whittam, D., Griffiths, M. J., Jacob, A., & Huda, S. (2021) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12630 · Cited by 17
Seronegative Neuromyelitis Optica Spectrum Disorder following Exposure to Hepatitis B Vaccination
Heekin, R., Gandhy, C., & Robertson, D. S. (2015) · Case Reports in Neurology · doi:10.1159/000381826 · Cited by 17
Diagnostic criteria for neuromyelitisoptica spectrum disorders
Belova, A. N., Bojko, A., & Белова, Е. М. (2016) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20161162232-40 · Cited by 19
Frequency of Autoantibodies and Connective Tissue Diseases in Chinese Patients with Optic Neuritis
Li, H., Zhang, Y., Yi, Z., Huang, D., & Wei, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099323 · Cited by 16
Myelin oligodendrocyte glycoprotein immunoglobulin G‐associated disease: An overview
Fujihara, K., Sato, D. K., Nakashima, I., Takahashi, T., Kaneko, K., Ogawa, R., Akaishi, T., Matsumoto, Y., Takai, Y., Nishiyama, S., et al. (2018) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12434 · Cited by 16
Immunopathology
Popescu, B. F. G., & Lucchinetti, C. F. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63432-0.00006-2 · Cited by 17
Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD)
Franciotta, D. M., Gastaldi, M., Sala, A., Andreetta, F., Rinaldi, E., Ruggieri, M., Leante, R., Costa, G., Biagioli, T., Massacesi, L., et al. (2017) · Neurological Sciences · doi:10.1007/s10072-017-3027-1 · Cited by 17
Immune-Mediated Myelopathies
Wingerchuk, D. M. (2018) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000582 · Cited by 16
Comparison of clinical characteristics and prognoses in patients with different AQP4-Ab and MOG-Ab serostatus with neuromyelitis optica spectrum disorders
Du, Q., Shi, Z., Chen, H., Zhang, Y., Wang, J., Qiu, Y., Zhao, Z., Zhang, Q., & Zhou, H. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577494 · Cited by 16
A nation-wide survey of Japanese pediatric MOG antibody-associated diseases
Azumagawa, K., Nakashima, I., Kaneko, K., Torisu, H., Sakai, Y., Kira, R., Sakuma, H., Tanaka, K., Shigeri, Y., Tanaka, Y., et al. (2021) · Brain and Development · doi:10.1016/j.braindev.2021.01.008 · Cited by 16
Neuromyelitis optica spectrum disorders: A nationwide Portuguese clinical epidemiological study
Santos, E., Rocha, A. L., Oliveira, V., Ferro, D., Samões, R., Sousa, A. P., Figueiroa, S., Mendonça, T., Abreu, P., Guimarães, J., et al. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103258 · Cited by 16
Retinal optical coherence tomography and magnetic resonance imaging in neuromyelitis optica spectrum disorders and MOG-antibody associated disorders: an updated review
Lin, T.-Y., Chien, C., Lu, A., Paul, F., & Zimmermann, H. G. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1982697 · Cited by 16
Meta-analysis of effectiveness of steroid-sparing attack prevention in MOG-IgG-associated disorder
Thakolwiboon, S., Zhao-Fleming, H. H., Karukote, A., Mao‐Draayer, Y., Flanagan, E. P., & Avila, M. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103310 · Cited by 16
Anti-Myelin Oligodendrocyte Glycoprotein and Human Leukocyte Antigens as Markers in Pediatric and Adolescent Multiple Sclerosis: on Diagnosis, Clinical Phenotypes, and Therapeutic Responses
Gontika, M. P., & Anagnostouli, M. C. (2018) · Multiple Sclerosis International · doi:10.1155/2018/8487471 · Cited by 17
Bilateral trigeminal root entry zone enhancement in MOG-IgG-associated brainstem encephalitis
Shen, Y., Cheng, Z., & Zhou, C. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3668-8 · Cited by 16

Authors: Sato, D. K., Callegaro, D., Lana-Peixoto, M. A., Waters, P. J., Jorge, F. M. D. H., Takahashi, T., Nakashima, I., Apostolos-Pereira, S. L., Talim, N., Simm, R. F., Lino, A. M. M., Misu, T., Leite, M. I., Aoki, M., & Fujihara, K.
Affiliations: Universidade Federal de Minas Gerais (BR)
From the Departments of Neurology (D.K.S., T.T., I.N., M.A.) and Multiple Sclerosis Therapeutics (T.M., K.F.), Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Neurology (D.C., F.M.d.H.J., S.L.A.-P., R.F.S., A.M.M.L.), Faculty of Medicine, University of São Paulo, Brazil; CIEM MS Research Center (M.A.L.-P., N.T.), Federal University of Minas Gerais Medical School, Belo Horizonte, Brazil; Neuroimmunology Group (P.J.W., M.I.L.), Nuffield Department of Clinical Neurosciences,...
ORCID: Sato, Douglas Kazutoshi
Callegaro, Dagoberto
Waters, Patrick J.
Takahashi, Toshiyuki
Nakashima, Ichiro
Lino, Angelina Maria Martins
Misu, Tatsuro
Leite, Maria Isabel
Aoki, Masashi
Fujihara, Kazuo
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2014-02-11
Volume: 82
Issue: 6
Pages: 474-481
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.0000000000000101
PMC: PMC3937859
OpenAlex: W2103812851
Cited by: 850
References: 21
Citations by year: 2026: 25 · 2025: 41 · 2024: 45 · 2023: 67 · 2022: 69 · 2021: 94 · 2020: 95 · 2019: 83 · 2018: 76 · 2017: 82 · 2016: 66 · 2015: 66 · 2014: 38
FWCI: 62.41
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
Locations: Neurology (publishedVersion, cc-by-nc-nd)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Japan Society for the Promotion of Science (22229008)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords: neuromyelitis optica spectrum disorder, anti-MOG antibodies, aquaporin-4 antibodies, seronegative NMOSD, clinical features, optic neuritis, spinal cord lesions, disease phenotypes, functional recovery, relapse rate
MeSH terms: Adolescent, Adult, Aged, Autoantibodies, Child, Preschool, Female, Humans, Male, Middle Aged, Neuromyelitis Optica, Phenotype, Sex Factors, Aquaporin 4, Young Adult, Myelin-Oligodendrocyte Glycoprotein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks